ALLERGY DRUG FOR MS NOTHING ITO SNEEZE AT!
National Enquirer|September 25, 2023
A COMMON allergy drug may pave the way toward future therapies for multiple sclerosis (MS)!
ALLERGY DRUG FOR MS NOTHING ITO SNEEZE AT!

Researchers at University of California, San Francisco used MRI scans to analyze the impact of the medication clemastine on the brains of 50 patients living with the chronic and incura disease of the central nervous system.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM NATIONAL ENQUIRERView all